ES2196262T3 - BENZOTIOPHENE COMPOUNDS, INTERMEDIATES, PROCEDURES AND USES. - Google Patents

BENZOTIOPHENE COMPOUNDS, INTERMEDIATES, PROCEDURES AND USES.

Info

Publication number
ES2196262T3
ES2196262T3 ES97304458T ES97304458T ES2196262T3 ES 2196262 T3 ES2196262 T3 ES 2196262T3 ES 97304458 T ES97304458 T ES 97304458T ES 97304458 T ES97304458 T ES 97304458T ES 2196262 T3 ES2196262 T3 ES 2196262T3
Authority
ES
Spain
Prior art keywords
benzotiophene
compounds
intermediates
procedures
pirrolidinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97304458T
Other languages
Spanish (es)
Inventor
George Joseph Cullinan
Kennan Joseph Fahey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2196262T3 publication Critical patent/ES2196262T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA NUEVOS COMPUESTOS DE BENZOTIOFENO DE FORMULA EN LA QUE: R1 ES C1 TITUIDO, TE SUSTITUIDO, O H, OPCIONALMENTE SUSTITUIDO, ENILO OPCIONALMENTE SUSTITUIDO, SON CADA UNO DE ELLOS INDEPENDIENTEMENTE ALQUILO C1 COMBINAN FORMANDO, CON EL NITROGENO AL CUAL ESTAN UNIDOS, PIPERIDINILO, PIRROLIDINILO, METILPIRROLIDINILO, DIMETILPIRROLIDINILO O HEXAMETILENIMINO; CON LA CONDICION DE QUE CUANDO N ES 3, ENTONCES NI R1 NI R2 PUEDEN SER O UNA SAL O SOLVATO FARMACEUTICAMENTE ACEPTABLE DE LOS MISMOS.THE PRESENT INVENTION PROVIDES NEW FORMULA BENZOTIOPHENE COMPOUNDS IN WHICH: R1 IS C1 TITUATED, SUBSTITUTED, OH, OPTIONALLY REPLACED, ENILO OPTIONALLY REPLACED, ARE EACH OF THEM INDEPENDENTLY RENT C1 COMBINED WITH ONE, FORMING PIPERIDINYL, PIRROLIDINYL, METHYLPIRROLIDINYL, DIMETHYL-PIRROLIDINYL OR HEXAMETILENIMINE; WITH THE CONDITION THAT WHEN N IS 3, THEN NEITHER R1 OR R2 MAY BE OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATO OF THE SAME.

ES97304458T 1996-07-02 1997-06-25 BENZOTIOPHENE COMPOUNDS, INTERMEDIATES, PROCEDURES AND USES. Expired - Lifetime ES2196262T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2102696P 1996-07-02 1996-07-02

Publications (1)

Publication Number Publication Date
ES2196262T3 true ES2196262T3 (en) 2003-12-16

Family

ID=21801903

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97304458T Expired - Lifetime ES2196262T3 (en) 1996-07-02 1997-06-25 BENZOTIOPHENE COMPOUNDS, INTERMEDIATES, PROCEDURES AND USES.

Country Status (7)

Country Link
US (1) US6432983B1 (en)
EP (1) EP0816360B1 (en)
JP (1) JPH1067776A (en)
AT (1) ATE236152T1 (en)
CA (1) CA2206752A1 (en)
DE (1) DE69720326T2 (en)
ES (1) ES2196262T3 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9308264B2 (en) 2000-11-08 2016-04-12 Fxs Ventures, Llc Ophthalmic contact lens solutions containing forms of vitamin B
JP2004531559A (en) 2001-05-22 2004-10-14 イーライ・リリー・アンド・カンパニー Tetrahydroquinoline derivatives for inhibiting diseases associated with estrogen deficiency or abnormal physiological response to endogenous estrogen
EP1395563B1 (en) 2001-05-22 2006-03-29 Eli Lilly And Company 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
US9962362B2 (en) 2012-03-29 2018-05-08 Children's Hospital Medical Center Use of small molecule inhibitors targeting EYA tyrosine phosphatase
WO2014113407A2 (en) 2013-01-16 2014-07-24 Children's Hospital Medical Center Use of small molecule inhibitors targeting eya tyrosine phosphatase

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1300575B (en) 1965-05-21 1969-08-07 Bristol Myers Co Benzo [b] thiophenes
US3394125A (en) 1965-10-23 1968-07-23 Bristol Myers Co 2-phenyl-3-tertiary-aminoalkoxy phenyl-and corresponding tertiaryaminoalkyl thio benzfurans substituted in the benzo nucleus with an alkoxy or tertiaryamino alkoxy or alkylthio group
US3947470A (en) * 1974-06-20 1976-03-30 Smithkline Corporation Substituted benzofurans and benzothiophenes
US4230862A (en) 1975-10-28 1980-10-28 Eli Lilly And Company Antifertility compounds
US4133814A (en) 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en) 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
GB2097788B (en) * 1981-04-03 1985-04-24 Lilly Co Eli Benzothiophene compounds and process for preparing them
US4358593A (en) 1981-04-03 1982-11-09 Eli Lilly And Company Process for preparing 3-(4-aminoethoxybenzoyl)benzo[b]thiophenes
WO1989002893A1 (en) 1987-09-30 1989-04-06 The University Of Tennessee Research Corporation Certain 3-substituted 2-alkyl benzothiophene derivatives
US5395842A (en) 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
DE4117512A1 (en) 1991-05-25 1992-11-26 Schering Ag 2-PHENYLBENZO (B) FURANES AND THIOPHENES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
JP3157882B2 (en) 1991-11-15 2001-04-16 帝国臓器製薬株式会社 New benzothiophene derivatives
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
TW383306B (en) * 1992-12-22 2000-03-01 Lilly Co Eli New use of 2-phenyl-3-aroylbenzothiophenes in lowering serum cholesterol
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US6756388B1 (en) 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US5457113A (en) * 1993-10-15 1995-10-10 Eli Lilly And Company Methods for inhibiting vascular smooth muscle cell proliferation and restinosis
JPH09507071A (en) * 1993-12-21 1997-07-15 イーライ・リリー・アンド・カンパニー Methods for treating or preventing conditions associated with amyloidogenic peptides
WO1995017382A1 (en) * 1993-12-21 1995-06-29 Eli Lilly And Company Non-peptide tachykinin receptor antagonists
US6399634B1 (en) * 1994-09-20 2002-06-04 Eli Lilly And Company Benzothiophene compounds, compositions, and methods
IL115582A0 (en) * 1994-10-14 1996-01-19 Lilly Co Eli Methods for treating resistant tumors
EP0895781A3 (en) * 1994-10-20 1999-07-07 Eli Lilly And Company Use of benzofurans, benzothiophenes or indoles for the manufacture of a medicament for the treatment of conditions associated with an excess of tachykinins
US5663192A (en) * 1994-10-20 1997-09-02 Eli Lilly And Company Heterocyclic neuropeptide Y receptor antagonists
EP0707852A3 (en) * 1994-10-20 1998-08-19 Eli Lilly And Company Bicyclic bradykinin receptor antagonists
US5552412A (en) * 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis

Also Published As

Publication number Publication date
CA2206752A1 (en) 1998-01-02
EP0816360A1 (en) 1998-01-07
US6432983B1 (en) 2002-08-13
EP0816360B1 (en) 2003-04-02
DE69720326T2 (en) 2003-11-27
ATE236152T1 (en) 2003-04-15
DE69720326D1 (en) 2003-05-08
JPH1067776A (en) 1998-03-10

Similar Documents

Publication Publication Date Title
SV2002000195A (en) PHARMACEUTICALLY ACTIVE COMPOUNDS REF. PCS10342 AFAE / BB
EA199700117A1 (en) TRICYCLIC BENZE-GOLDEN ANTAGONISTS VAZOPRESSIN, METHOD FOR THEIR RECOVERY, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT OF MAMMALS USING Tricyclic Benzene
ES2196344T3 (en) DERIVATIVES OF SULFONAMIDE AND ITS USE IN THE TREATMENT OF CNS DISORDERS.
ES2195970T3 (en) L-RIBAVIRINA AND USES OF THE SAME.
ATE200279T1 (en) PREPARATION OF 3,4,4-TRIS-SUBSTITUTED PIPERIDINYL-N-ALKYLCARBOXYLATES AND INTERMEDIATE COMPOUNDS USABLE AS OPIOID ANTAGONISTS
GT199900067A (en) NEW 4-PHENYLPIPERIDINES FOR THE TREATMENT OF PRURTIC DEDERMATOSIS.
ECSP941135A (en) BENZACEPINE VASOPRESSIN TRICYCLIC ANTAGONISTS
GT199600026A (en) ISOTIAZOLONES
ES2162198T3 (en) STROGEN AGENTS.
DE69429524D1 (en) AMINOCYCLOHEXYLESTER AND THEIR USE
IT1098168B (en) PROCEDURE FOR THE JOINING OF HEARTS OF RAILWAY EXCHANGES, HEARTS WHICH ARE MADE OF HARD MELTED STEEL WITH MANGANESE, WITH RAILS MADE OF CARBON STEEL
ES2168613T3 (en) EMPLOYMENT OF HYDROSOLUBLE COPOLYMERS AS ACTIVE PRINCIPLES IN COSMETIC FORMULATIONS.
ATE225349T1 (en) CRF RECEPTOR ANTAGONISTS AND RELATED METHODS
DE68902784D1 (en) INTERCHANGEABLE QUENCH GAS INJECTION RING.
CO4970722A1 (en) ERYTHROMYCIN DERIVATIVES WITH BRIDGE IN 6, 9
TR200200263T2 (en) New selective retinoid agonists
DE69229339D1 (en) CRYSTALLINE TIAGABINE HYDROCHLORIDE MONOHYDRATE, ITS PRODUCTION AND USE
ES2171911T3 (en) CONFORMATIONALLY RESTRICTED POLYAMINS AND ITS USE AS ANTINEOPLASIC AGENTS.
ES2110260T3 (en) ANDROSTENONAS.
FI974434L (en) Tricyclic 5,6-dihydro-9H-pyrazolo(3,4-c)-1,2,4,-triazolo(4,3-alphapyridines
ES2158077T3 (en) ARTROPODICID OXIDIACINIC CARBOXANILIDS.
ES2196262T3 (en) BENZOTIOPHENE COMPOUNDS, INTERMEDIATES, PROCEDURES AND USES.
ES2195089T3 (en) BENZOTIOPHENES AMORPHES, PREPARATION AND USE PROCEDURES.
UA41350C2 (en) MORPHOLINE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT AND PHARMACEUTICAL COMPOSITION BASED ON IT
ES2149193T3 (en) HETEROCICLIC COMPOUNDS REPLACED WITH RENT.